Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Peter Tonge
State University New York Stony Brook, Department: Chemistry
Should you be removed from our database? Contact us at [email protected]. Read more below.
Chronus Pharamceuticals
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Tonge is a co-founder of Chronus Pharmaceuticals and principal investigator of this grant. If the research is successful, Chronus Pharmaceuticals is a potential licensee.
Novel PET Radiotracers for Imaging Infection
Project Narrative Many human infections such as osteomyelitis and endocarditis, as well as infections of prosthetic joints, are difficult to detect and treat due to their location in the human body. To meet this unmet medical need, we will develop radiotracers that can be used for non-invasive imaging to detect and localize bacterial pathogens in humans. Such radiotracers will distinguish between different pathogen populations, serve as non-invasive diagnostics and inform on bacterial load during chemotherapy, thereby identifying and improving treatment of patients with infectious diseases.
Filed on September 21, 2018.
Tell us what you know about Peter Tonge's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Peter Tonge”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Peter Tonge | State University New York Stony Brook | Conflict of Interest | Chronus Pharmaceuticals | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.